Cision Vision, founded in 2019, is a medical technology company specializing in advanced imaging solutions for anatomical pathology and surgical oncology. Based in Mountain View, California, the company is known for its innovative imaging devices that enhance the visualization and analysis of lymph nodes without the need for injections or radiation. Among their flagship products is the InVision device, which has received recognition for revolutionizing cancer staging and treatment processes. The company was co-founded by Jeremy Li and has garnered attention for its cutting-edge technology in the life sciences market.
| Attribute | Information |
|---|---|
| Founding Date | 2019 |
| Headquarters | Mountain View, California, USA |
| Founders | Jeremy Li |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Various healthcare-focused investors |
| Industry | Medical Technology |
| Number of Employees | Approximately 100 |
Cision Vision was established with the goal of improving the standard of care in surgical oncology through innovative imaging technology. The idea for the company took root when co-founder Jeremy Li, with a background in biomedical engineering, recognized the need for enhanced imaging methods in the diagnosis and treatment of cancer. Within its first year, the company successfully developed prototype devices and began testing in collaboration with leading healthcare institutions. This early focus on collaboration with medical professionals allowed Cision Vision to tailor its technology to meet clinical needs effectively.
Cision Vision's business model centers around the development and commercialization of advanced imaging devices for use in healthcare facilities. Their signature product, InVision, helps pathologists and surgeons visualize lymph nodes in real time, significantly improving the accuracy of cancer diagnosis and the effectiveness of subsequent treatments.
Currently, Cision Vision operates primarily within the United States, with plans to expand its market reach internationally. The company positions itself as a leader in medical imaging for oncology, leveraging proprietary technology to address limitations of traditional imaging methods. Cision Vision competes with larger imaging companies but differentiates itself through its specialized technology, which eliminates the need for contrast agents or radiation. They continue to invest in research and development to maintain their competitive edge and enhance their market share.
Cision Vision has established itself as a significant player in the medical imaging technology sector in just a few years. Through innovative solutions like the InVision device, they offer substantial improvements in the care and management of cancer patients. Looking forward, Cision Vision aims to broaden its global presence and continue setting new standards in medical imaging technology, positioning itself for sustained growth and impact in healthcare.